If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

Neuroblastoma Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Glioma Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Cells Chemical Compounds
Phenotype Medicine & Life Sciences
Alendronate Medicine & Life Sciences
Centrosome Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

  • 82 Citations
  • 6 h-Index
  • 8 Article

Altered function of the glutamate–aspartate transporter GLAST, a potential therapeutic target in glioblastoma

Corbetta, C., Di Ianni, N., Bruzzone, M. G., Patanè, M., Pollo, B., Cantini, G., Cominelli, M., Zucca, I., Pisati, F., Poliani, P. L., Finocchiaro, G. & Pellegatta, S., Jan 1 2019, (Accepted/In press) In : International Journal of Cancer.

Research output: Contribution to journalArticle

Glutamic Acid
5 Citations (Scopus)

Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy

Pellegatta, S., Savoldo, B., Di Ianni, N., Corbetta, C., Chen, Y., Patané, M., Sun, C., Pollo, B., Ferrone, S., DiMeco, F., Finocchiaro, G. & Dotti, G., Feb 28 2018, In : Science Translational Medicine. 10, 430, eaao2731.

Research output: Contribution to journalArticle

Antigen Receptors
Cell- and Tissue-Based Therapy
Tumor Necrosis Factor-alpha
7 Citations (Scopus)

The multidrug-resistance transporter Abcc3 protects NK cells from chemotherapy in a murine model of malignant glioma

Pessina, S., Cantini, G., Kapetis, D., Cazzato, E., Di Ianni, N., Finocchiaro, G. & Pellegatta, S., Apr 18 2016, (Accepted/In press) In : OncoImmunology.

Research output: Contribution to journalArticle

Multiple Drug Resistance
Natural Killer Cells
Drug Therapy
10 Citations (Scopus)

The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype

Ruggeri, P., Farina, A. R., Di Ianni, N., Cappabianca, L., Ragone, M., Ianni, G., Gulino, A. & Mackay, A. R., Apr 15 2014, In : PLoS One. 9, 4, e94568.

Research output: Contribution to journalArticle

Neoplastic Stem Cells
Oncogene Proteins
Stem cells
8 Citations (Scopus)

TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype

Farina, A. R., Di Ianni, N., Cappabianca, L., Ruggeri, P., Ragone, M., Ianni, G., Gulino, A. & Mackay, A. R., 2013, In : BioMed Research International. 2013, 740187.

Research output: Contribution to journalArticle